Nasopharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-08-22Clinical Trial Update: Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer [NA]
This clinical trial update discusses evaluating a different sequence of chemoradiotherapy and a modified radiotherapy schedule for advanced …
-
CLINICAL_TRIALS research · 2013-05-15Clinical Trial Update: Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating fluorouracil, cisplatin, and radiation therapy for nasopharyngeal cancer.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with cisplatin, radiation, and fluorouracil in stage IIB to IVB nasopharyngeal cancer completed with re…
-
CLINICAL_TRIALS research · 2013-03-29Clinical Trial Update: Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis [Phase 2]
Phase 2 clinical trial evaluating recombinant human GM-CSF (rhGM-CSF) for treating oral mucositis in patients with nasopharyngeal cancer; cu…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This document provides an update on a Phase 2 trial of sorafenib for patients with recurrent or metastatic head and neck cancer and indicate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Assessment of New Radiation Oncology Technologies and Treatments
This clinical trial update reports completion of a study evaluating new radiation oncology technologies and treatments. The study assessed m…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating bortezomib in combination with gemcitabine for recurrent or metastatic nasopharyngeal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx [Phase 2]
Phase 2 trial evaluating chemotherapy plus radiation with or without amifostine for locally advanced nasopharyngeal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial evaluating the efficacy of zoledronic acid (ZOMETA) for treating bone metastases in patients with stage IV nasopharyn…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer [Phase 2]
Phase 2 study evaluating gemcitabine and cisplatin/carboplatin with erlotinib in nasopharyngeal cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intensity-modulated radiation therapy to treat nasopharyngeal cancer while sparing the contralateral par…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating Gemcitabine and Oxaliplatin (GEMOX) as first-line treatment for metastatic or recurrent nasopharyngeal cancer has c…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy for nasopharyngeal cancer (Stage IIB/III/IV). The provided information not…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer [Phase 1]
A Phase 1 clinical trial of a peptide vaccine to prevent recurrence of nasopharyngeal cancer has completed.